Search Tag: Extracorporeal Membrane Oxygenation


2021 01 Sep

At the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine this week, Professor Alain Combes of Sorbonne University, Paris, talked about treating COVID-19 patients with the most severe forms of cardiac and respiratory failure.   Prof Combes talked about his experience during the pandemic and presented his research that compared... Read more

Safe Liberation During Weaning from VV-ECMO

2021 28 Jun

The use of venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with severe acute respiratory distress syndrome (ARDS) has increased substantially over the last few years. However, conclusive evidence supporting its use is still lacking, and mortality of patients treated with VV-ECMO for ARDS is still high.   Optimal strategies of... Read more


2021 22 Jun

Extracorporeal membrane oxygenation (ECMO) has been used in patients with COVID-19 who develop severe acute respiratory distress syndrome (ARDS). ECMO has previously been used in other infectious outbreaks, including the 2009 influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak.   The Extracorporeal Life Support... Read more

Novalung System Receives US FDA Clearance

2020 26 Feb

The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios, a Fresenius Medical Care company, for long-term use of its Novalung system for patients with acute lung failure or acute cardiopulmonary failure. The FDA announced this on Friday evening. With class II approval, the Novalung... Read more

Lung Recruitment in Patients with Severe ARDS

2019 30 Aug

Acute Respiratory Distress Syndrome (ARDS) affects up to 10% of patients in the ICU. Typical symptoms of ARDS include an increase in lung weight and a reduction of aerated lung tissue. For the treatment of ARDS alveolar recruitment is key, however, this has not yet been shown to benefit severe ARDS cases. It has been suggested that lung recruitment... Read more

Models for predicting outcome in patients under VA-ECMO

2019 20 Feb

Despite limited evidence, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for the management of refractory cardiogenic shock (RCS) while awaiting myocardial recovery or the bridge to long-term assistance or transplantation. However, despite technological advances and better quality of care, mortality still remains at... Read more

High-risk ECMO - heroic rescue or futile care?

2018 26 Sep

Over the past decade, extracorporeal membrane oxygenation (ECMO) has become mainstream therapy in adult intensive care. Although the list of contraindications to ECMO has shrunk considerably, a few of these remain absolute, notes Dr. Graeme MacLaren in an editorial article published in the journal Critical Care.  "There are a number of circumstances... Read more

Despite ECMO use, mortality remains high in patients with cardiogenic shock

2018 11 Jul

An analysis of ECMO – extracorporeal membrane oxygenation – use in patients with cardiogenic shock finds that mortality remains high despite increasing utilisation of the resource-intensive intervention in this population. Season of admission (other than Fall) and presence of specific comorbidities (respiratory and genitourinary diseases) are associated... Read more

New model for predicting ECMO outcome in ARDS

2017 19 Dec

Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy in acute respiratory distress syndrome (ARDS) patients but is associated with complications and costs. Researchers in Germany have developed a new, simple model that also incorporates extrapulmonary variables to predict mortality in ECMO-treated ARDS patients. The PRESET-Score (PREdiction... Read more